These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 36982809)

  • 1. Erythrocytes Functionality in SARS-CoV-2 Infection: Potential Link with Alzheimer's Disease.
    Kosenko E; Tikhonova L; Alilova G; Montoliu C
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Neuropathological Impacts of COVID-19: Challenges and Alternative Treatment Options for Alzheimer's Like Brain Changes on Severely SARS-CoV-2 Infected Patients.
    Rahman MR; Akter R; Neelotpol S; Mayesha II; Afrose A
    Am J Alzheimers Dis Other Demen; 2023; 38():15333175231214974. PubMed ID: 37972355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and erythrocrine function: The roller coaster and danger.
    Al-Kuraishy HM; Al-Gareeb AI; Onohuean H; El-Saber Batiha G
    Int J Immunopathol Pharmacol; 2022; 36():3946320221103151. PubMed ID: 35590466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Exacerbates Beta-Amyloid Neurotoxicity, Inflammation and Oxidative Stress in Alzheimer's Disease Patients.
    Chiricosta L; Gugliandolo A; Mazzon E
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The COVID-19 pandemic and Alzheimer's disease: mutual risks and mechanisms.
    Chen F; Chen Y; Wang Y; Ke Q; Cui L
    Transl Neurodegener; 2022 Sep; 11(1):40. PubMed ID: 36089575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer's disease brain.
    Zhao Y; Li W; Lukiw W
    Folia Neuropathol; 2021; 59(3):232-238. PubMed ID: 34628788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 as a Risk Factor for Alzheimer's Disease.
    Golzari-Sorkheh M; Weaver DF; Reed MA
    J Alzheimers Dis; 2023; 91(1):1-23. PubMed ID: 36314211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combating hypoxemia in COVID-19 patients with a natural oxygen carrier, HEMO
    Lupon E; Lellouch AG; Zal F; Cetrulo CL; Lantieri LA
    Med Hypotheses; 2021 Jan; 146():110421. PubMed ID: 33308935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease.
    Rai SN; Tiwari N; Singh P; Singh AK; Mishra D; Imran M; Singh S; Hooshmandi E; Vamanu E; Singh SK; Singh MP
    Oxid Med Cell Longev; 2022; 2022():3012778. PubMed ID: 36092161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer's Disease.
    Ding Q; Shults NV; Gychka SG; Harris BT; Suzuki YJ
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment.
    Zhou Y; Xu J; Hou Y; Leverenz JB; Kallianpur A; Mehra R; Liu Y; Yu H; Pieper AA; Jehi L; Cheng F
    Alzheimers Res Ther; 2021 Jun; 13(1):110. PubMed ID: 34108016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer's Disease.
    Kosenko EA; Tikhonova LA; Montoliu C; Barreto GE; Aliev G; Kaminsky YG
    Front Neurosci; 2017; 11():728. PubMed ID: 29354027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of the Purinergic and Cholinergic Anti-inflammatory Pathways on Oxidative Stress in Patients with Alzheimer's Disease in the Context of the COVID-19 Pandemic.
    Simões JLB; Sobierai LD; Leal IF; Dos Santos MVR; Coiado JV; Bagatini MD
    Neuroscience; 2023 Feb; 512():110-132. PubMed ID: 36526078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 and neurodegenerative diseases.
    Fu YW; Xu HS; Liu SJ
    Eur Rev Med Pharmacol Sci; 2022 Jun; 26(12):4535-4544. PubMed ID: 35776055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-COVID is Associated with Impaired Red Blood Cell Function.
    Kronstein-Wiedemann R; Tausche K; Kolditz M; Teichert M; Thiel J; Koschel D; Tonn T; Künzel SR
    Horm Metab Res; 2024 Apr; 56(4):318-323. PubMed ID: 37890507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and Alzheimer's Disease: A Literature Review.
    Hardan L; Filtchev D; Kassem R; Bourgi R; Lukomska-Szymanska M; Tarhini H; Salloum-Yared F; Mancino D; Kharouf N; Haikel Y
    Medicina (Kaunas); 2021 Oct; 57(11):. PubMed ID: 34833377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 and Alzheimer's disease: how one crisis worsens the other.
    Xia X; Wang Y; Zheng J
    Transl Neurodegener; 2021 Apr; 10(1):15. PubMed ID: 33941272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.